Seilern Investment Management Ltd Makes New $153.02 Million Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Seilern Investment Management Ltd purchased a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 302,484 shares of the healthcare conglomerate's stock, valued at approximately $153,015,000. UnitedHealth Group accounts for 8.7% of Seilern Investment Management Ltd's portfolio, making the stock its 3rd largest holding.

Several other large investors also recently made changes to their positions in the business. International Assets Investment Management LLC grew its position in UnitedHealth Group by 78,814.4% in the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate's stock worth $3,096,896,000 after purchasing an additional 5,290,025 shares during the last quarter. Lone Pine Capital LLC acquired a new position in shares of UnitedHealth Group in the 2nd quarter worth approximately $480,903,000. Accredited Investors Inc. lifted its position in shares of UnitedHealth Group by 9,235.4% in the 3rd quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate's stock valued at $458,929,000 after acquiring an additional 776,516 shares in the last quarter. Raymond James & Associates grew its position in UnitedHealth Group by 33.1% during the third quarter. Raymond James & Associates now owns 2,361,396 shares of the healthcare conglomerate's stock valued at $1,380,661,000 after purchasing an additional 587,088 shares in the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec grew its stake in shares of UnitedHealth Group by 129.7% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate's stock valued at $601,951,000 after buying an additional 581,324 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Analyst Ratings Changes

UNH has been the topic of a number of research analyst reports. Oppenheimer raised their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an "outperform" rating in a research note on Friday, December 6th. Barclays cut their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research note on Friday. Royal Bank of Canada cut their target price on UnitedHealth Group from $615.00 to $595.00 and set an "outperform" rating for the company in a research report on Wednesday, October 16th. UBS Group dropped their price objective on UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating for the company in a research note on Wednesday, October 16th. Finally, Cantor Fitzgerald reiterated an "overweight" rating and set a $700.00 target price on shares of UnitedHealth Group in a research report on Friday. Two investment analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group has an average rating of "Buy" and an average price target of $627.74.

UnitedHealth Group Trading Down 0.1 %

NYSE:UNH traded down $0.56 during trading hours on Monday, hitting $510.03. The stock had a trading volume of 7,462,712 shares, compared to its average volume of 5,104,531. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The business's 50 day moving average is $549.37 and its 200-day moving average is $563.70. The company has a market cap of $469.37 billion, a price-to-earnings ratio of 33.23, a P/E/G ratio of 1.42 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same period in the previous year, the firm earned $5.83 EPS. UnitedHealth Group's quarterly revenue was up 6.8% compared to the same quarter last year. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were issued a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.65%. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.